Stay updated with breaking news from Launch Dynamix. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- In May of 2022, Sanofi/Regeneron's Dupixent (dupilumab) was granted approval by the U.S. FDA to treat eosinophilic esophagitis (EoE) in adults...
/PRNewswire/ -- Over the course of this year, AbbVie has proven successful in expanding their immunology portfolio to offset potential Humira losses with the...
/PRNewswire/ -- Over the course of this year, AbbVie has proven successful in expanding their immunology portfolio to offset potential Humira losses with the...
/PRNewswire/ -- Competition in the generalized myasthenia gravis (gMG) market is heating up with the launches of argenx's Vyvgart and Alexion's Ultomiris...
/PRNewswire/ -- Competition in the generalized myasthenia gravis (gMG) market is heating up with the launches of argenx's Vyvgart and Alexion's Ultomiris...